StockData
Sanara MedTech Inc. logo

Sanara MedTech Inc. (SMTI) stock

SMTINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30144% above fair value
$32.73+0.00 (0.00%)

Close on Nov 18, 2026Market cap $300.72MP/E –Yield –

Sanara MedTech r&d expenses

Research and development expenses are spending on new products and technology.

Sanara MedTech's R&D Expenses for the twelve months ending Jun 30, 2026 was $4.98M, up 35.5% year over year. For fiscal 2025 it was $5.07M, up 79.3% from the year before. The highest annual figure on record is $5.07M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.07M+79.3%
FY2024Dec 31, 2024$2.83M-31.5%
FY2023Dec 31, 2023$4.13M+22.7%
FY2022Dec 31, 2022$3.37M+502.7%
FY2021Dec 31, 2021$558.70K+1290.2%
FY2020Dec 31, 2020$40.19K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.15M+9.2%
Q1 FY2026Mar 31, 2026$759.59K-20.1%
Q4 FY2025Dec 31, 2025$2.04M+130.4%
Q3 FY2025Sep 30, 2025$1.03M+31.4%
Q2 FY2025Jun 30, 2025$1.06M+7.2%
Q1 FY2025Mar 31, 2025$950.36K+0.4%
Q4 FY2024Dec 31, 2024$883.40K+35.6%
Q3 FY2024Sep 30, 2024$783.84K-20.5%
Q2 FY2024Jun 30, 2024$985.65K-16.3%
Q1 FY2024Mar 31, 2024$946.30K-28.2%
Q4 FY2023Dec 31, 2023$651.52K-37.0%
Q3 FY2023Sep 30, 2023$986.45K-7.1%
Q2 FY2023Jun 30, 2023$1.18M+10.3%
Q1 FY2023Mar 31, 2023$1.32M+543.7%
Q4 FY2022Dec 31, 2022$1.03M+243.7%
Q3 FY2022Sep 30, 2022$1.06M+2875.2%
Q2 FY2022Jun 30, 2022$1.07M+926.1%
Q1 FY2022Mar 31, 2022$204.64K+73.1%
Q4 FY2021Dec 31, 2021$300.84K+931.4%
Q3 FY2021Sep 30, 2021$35.67K+223.7%
Q2 FY2021Jun 30, 2021$103.98K+150.5%
Q1 FY2021Mar 31, 2021$118.21K+2594.6%
Q4 FY2020Dec 31, 2020$29.17K–
Q3 FY2020Sep 30, 2020$11.02K–
Q2 FY2020Jun 30, 2020$41.52K–
Q1 FY2020Mar 31, 2020$4.39K–

More Sanara MedTech figures

See a number that looks wrong?